Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib PK with Ketoconazole or Esomeprazole
NCT01205230Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pazopanib in solid tumor (2 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Zero to 24 Hours, Maximum Observed Concentration and 1 more. Started Sep 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01205230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205230.